PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.\', \'Institute for Medical Virology and Epidemiology, University Hospital Tübingen, Tübingen, Germany.\', \'Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany.\', \'Pharmaceutical Biotechnology, University of Tübingen, Tübingen, Germany.\', \'Department of Anaesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'German Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.\', \'Signatope GmbH, Reutlingen, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies\', University of Tübingen, Tübingen, Germany.\', \'Department of Women\'s Health, Research Institute for Women\'s Health, University of Tübingen, Tübingen, Germany.\', \'Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, USA.\', \'Helmholtz Centre for Infection Research, Braunschweig, Germany.\', \'TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.\', \'Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. Ulrich.rothbauer@nmi.de.\', \'Pharmaceutical Biotechnology, University of Tübingen, Tübingen, Germany. Ulrich.rothbauer@nmi.de.\', \'Institute for Medical Virology and Epidemiology, University Hospital Tübingen, Tübingen, Germany. Michael.Schindler@med.uni-tuebingen.de.\', \'NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. Nicole.schneiderhan@nmi.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-23473-6
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34035301
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34035301>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34035301>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all